Euflexxa

DEVICE5 trials

Sponsors

Georgia Institute for Clinical Research, LLC, The Hawkins Foundation, University of California, San Francisco, Bioventus LLC, The Cleveland Clinic

Conditions

Chondropathy/Degenerative Joint Disease (DJD)Knee OsteoarthritisMeniscus TearOsteo Arthritis KneeOsteoarthritis

Phase 4

To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection

CompletedNCT01895959

University of California, San FranciscoKnee Osteoarthritis

Start: 2013-08-31End: 2017-01-31Updated: 2020-11-18

Unknown Phase

Three Injections of EUFLEXXA (Sodium Hyaluronate) for Treatment of Chronic Shoulder Pain Associated With Osteoarthritis (OA)

CompletedNCT00969501

Georgia Institute for Clinical Research, LLCOsteoarthritis

Start: 2009-08-31End: 2010-08-31Updated: 2013-05-07

Post-op Treatment With Hyaluronic Acid Injections

TerminatedNCT01256788

The Hawkins FoundationChondropathy/Degenerative Joint Disease (DJD), Meniscus Tear

Start: 2010-09-30End: 2014-04-30Updated: 2019-01-08

Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA

CompletedNCT02110238

Bioventus LLCOsteoarthritis

Start: 2014-03-31End: 2015-02-28Updated: 2021-03-09

Euflexxa for the Treatment of Osteoarthritis

CompletedNCT03459365

The Cleveland ClinicOsteo Arthritis Knee

Start: 2018-07-09End: 2021-10-31Updated: 2024-09-04